United Therapeutics Corp

NASDAQ:UTHR   4:00:00 PM EDT
290.91
+3.56 (+1.24%)
4:46:00 PM EDT: $290.91 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)13.12B
Current PE10.84
Forward PE 10.43
2yr Forward PE 9.91
See more stats
Estimates Current Quarter
Revenue$804.98 Million
Adjusted EPS$7.35
See more estimates
10-Day MA$288.99
50-Day MA$300.76
200-Day MA$336.93
See more pivots

United Therapeutics Corp Stock, NASDAQ:UTHR

1000 Spring Street, Silver Spring, Maryland 20910
United States of America
Phone: +1.301.608.9292
Number of Employees: 1305

Description

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.